Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:affiliatedWith |
benzodiazepine
|
| gptkbp:antidote |
gptkb:flumazenil
|
| gptkbp:ATCCode |
N05CD08
|
| gptkbp:availableOn |
injection
oral syrup nasal spray |
| gptkbp:brand |
gptkb:midazolam
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
severe respiratory insufficiency |
| gptkbp:discoveredBy |
gptkb:Hoffmann-La_Roche
|
| gptkbp:eliminationHalfLife |
1.5 to 2.5 hours
|
| gptkbp:genericName |
gptkb:midazolam
|
| https://www.w3.org/2000/01/rdf-schema#label |
Hypnovel
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
1982
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
gptkb:D_(Australia)
D (US) |
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous rectal |
| gptkbp:sideEffect |
gptkb:center
drowsiness hypotension respiratory depression |
| gptkbp:usedFor |
anesthesia induction
procedural sedation sedation treatment of seizures |
| gptkbp:usedIn |
emergency medicine
intensive care preoperative sedation |
| gptkbp:bfsParent |
gptkb:Dormicum
|
| gptkbp:bfsLayer |
7
|